Castle Creek Biosciences, Llc.

This study is testing a personalized cell therapy called D-Fi to see if it helps heal stubborn wounds in people with dystrophic epidermolysis bullosa (DEB), a painful genetic condition that causes fragile, blistering skin. In the trial, each participant's own skin cells are genet…

This study is testing whether a new gene therapy called FCX-007 can help heal wounds in people with recessive dystrophic epidermolysis bullosa (RDEB), a painful and severe genetic condition that causes fragile, blistering skin. The therapy involves taking a patient's own skin cel…